Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Note: 2018 data is provisional; Data: Centers for Disease Control; Chart: Axios Visuals

Fewer Americans died from drug overdoses last year than the year before. It's the first time that number has gone down in almost 30 years.

Yes, but: This progress is both fragile and modest. Overdose deaths fell by about 5% last year, according to provisional data from the federal government. But overdose deaths rose by roughly 316% between 1999 and 2017. There's still a long way to go, and more than 68,000 Americans still died of overdoses last year.

  • "Lives are being saved, and we're beginning to win the fight against this crisis," Health and Human Services Secretary Alex Azar said in a statement yesterday.
  • "This crisis developed over two decades and it will not be solved overnight," Azar said.
  • Overdoses from prescription opioids are falling, but deaths from fentanyl, cocaine and meth all continued to increase last year.

Between the lines: The decline in overall mortality appears to be driven mainly by a decline in the abuse of prescription painkillers. But overdoses involving fentanyl, cocaine and meth are all continuing to increase.

  • Naloxone, the drug that reverses the immediate effects of an overdose, has also become much more widely available as the crisis has worsened, and that is all but certainly helping to save lives.
  • But it's not clear whether efforts to get people into longer-term treatment programs are making a dent yet, given the rising demand for illegal drugs.

Go deeper: How to change treatment for opioid addiction

Go deeper

The manufacturing boom's bottleneck

llustration: Rebecca Zisser/Axios

The manufacturing sector has bounced back from its pandemic knockout. But as the economy reopens, factories can't keep up with orders.

Why it matters: The materials manufacturers need are hard to find and prices for them are soaring.

2 hours ago - Technology

Twitter to label COVID-19 vaccine misinformation, implement strike policy

Photo: Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images

Twitter announced Monday that it will label tweets with potentially misleading information about COVID-19 vaccines, and introduce a strike system that can lead to permanent account suspension.

The big picture: Tech companies are taking an increasingly aggressive stance against users who attempt to share misleading information about COVID-19 vaccines on their platforms.

Updated 4 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Health: Trump, Melania received COVID vaccine at White House in January — CDC director warns "now is not the time" to lift COVID restrictions.
  2. Vaccine: J&J CEO "absolutely" confident in vaccine distribution goals Most states aren't prioritizing prisons for COVID vaccines — Vaccine hesitancy is shrinking.
  3. Economy: Apple says all U.S. stores open for the first time since start of pandemic — What's really going on with the labor market.
  4. Sports: Poll weighs impact of athlete vaccination.
  5. World: Italy tightens restrictions as experts warn of growing prevalence of variants — PA announces new COVID restrictions as cases surge.
  6. Local: Colorado sets timeline for return to normalcy.